A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Clinical trial NCT07229586 · RECRUITING
Trial details
- NCT number
- NCT07229586
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-02
- Primary completion
- 2027-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.